Astra Zeneca announced promising results of a phase 3 trial of Farxiga, which showed to reduce the progression of kidney disease or renal death in …

Janssen Pharmaceutical, a Johnson and Johnson company, announced the U.S. Food and Drug Administration (FDA) has granted priority review for the …

Renalytix AI, a company developing of artificial intelligence-enabled clinical diagnostics for kidney disease, announced that it has been granted …

A new landmark clinical trial from Standford Medicine shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes …

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the …

The U.S. Food and Drug Administration (FDA) has approved a label update for AstraZeneca’s FARXIGA® (dapagliflozin) and XIGDUO® XR …

Vitamin B supplements have a protective effect on kidney function in children and adolescents with Type 1 diabetes, according to new research. The …

The kidneys are vital organs in the human body and are responsible for “cleaning” blood of waste and toxins. If you have diabetes and …

Proper treatment and refraining from smoking can significantly reduce the risk of cardiovascular disease resulting from Type 2 diabetes, a new …